or in STEMI patients, emergency surgical therapy within the first hours is indicated. Operative mortality for these patients using conventional arrested heart CABG techniques ranges from 1.6% to 32% and strongly depends on the preoperative hemodynamic condition. 14 -20 It can be speculated that preserving native coronary blood flow reduce reperfusion injury or "no reflow" phenomenon and advantages of BH surgery might be clinical significant just in emergency ACS patients. However, until now not much evidence exist on that issue and only few post hoc analyses have analyzed the impact on morbidity and mortality by using BH approaches in these patients. [21] [22] [23] [24] Therefore, the aim of this study was to analyze our 5-year experience on patients with ACS and having an indication for emergency CABG surgery within the first 12 hours after onset of symptoms comparing BH and arrested heart CABG. Propensity score adjusted multiregression analysis was used to assess in-hospital and follow-up outcome on patients with or without preoperative cardiogenic shock (CS).
Patients and Methods
BH surgery was introduced as an alternative surgical strategy for emergency treatment of ACS at our institution in the year 2000. A total of 19.218 isolated CABG procedures were performed from January 2000 until September 2005; 638 (3.3%) of the patients with ACS and had an emergency indication (ie, within 12 hours after presentation) according to the current guidelines. 25 Also, 240 patients underwent BH operation and 398 received conventional CA; 107 patients were in acute CS. Only patients receiving conventional sternotomy and CABG surgery without any additional cardiac procedure were included in this evaluation. UA was present in 304 patients (47.7%), NSTEMI in 152 (23.8%), and STEMI in 182 (28.5%) patients, respectively. Indication for emergency operation (partly multiple) were (1) failed percutaneous coronary intervention (PCI) in STEMI patients (nϭ42); (2) ongoing ischemia despite optimal medical therapy in patients presenting primary CABG indication 25 (nϭ454); (3) ongoing ischemia despite successful or failed PCI (n ϭ59); (4) eventful or complicated PCI (n ϭ62); and (5) CS with complex coronary anatomy not suitable for PCI (n ϭ107).
Diagnosis of AMI was made by conventional ECG in addition to enzyme or cardiac troponin criteria and confirmed by acute coronary angiography. Patients with ongoing angina without AMI character- Postoperative new onset of MI was defined when new q-wave or ST-segment elevation combined with new creatinine kinase MB fraction (CKMB) peak were present after initial enzyme drop. If it was considered, patients were immediately transferred for repeat angiography. Postoperative acute renal failure was defined as requirement for continuous veno-venous hemofiltration. Stroke was defined as transient or persisting postoperative hemiparesis or neurological dysfunction with morphological substrate confirmed by computer tomography or nuclear magnetic resonance imaging. Major adverse cerebral and cardiovascular events (MACCE) were assessed for all major cerebrovascular and cardiac events including death of all cause. Repeated revascularization was defined for all percutaneous coronary interventions irrespective of clinical symptoms. Indications were based on myocardial ischemia found during conventional diagnostic procedures, but not on the status of incomplete revascularization.
Surgical Technique
Routine sternotomy and internal mammary artery takedown were applied. BH surgery was performed using 2 pericardial traction sutures and a commercially available mechanical stabilizer. No preconditioning or intracoronary shunt insertions were performed. Proximal coronary snares were used when required. All anastomoses were performed using 7-0 or 8-0 monofilament sutures. The internal mammary artery (IMA) to the left anterior descending artery (LAD) was the first anastomosis in all patients, except that another culprit lesion was clearly identified. For LAD revascularization, IMA was used in all patients. In case of CS, patients first were connected to the cardiopulmonary bypass (CPB), followed by IMA harvesting. All patients received Aprotinin (Trasylol) at a dose of 2 million units. OPCAB patients received 150 IU/kg and on-pump patients 300 IU/kg of heparin. CPB was established by standard ascending aortic and right atrial cannulation. Moderate hypothermia of 32°C to 33°C was applied. At the end of the operation heparin was antagonized with protamine sulfate. A cell saver was used in OPCAB patients. Completeness of revascularization was expressed by the index for completeness of revascularization indicating the performed related to planned distal anastomoses. Full surgical revascularization was the aim in all patients and hybrid procedures were not primarily indicated.
Data Analysis
All data were prospectively recorded. Analyses were separately performed for patients with and without preoperative CS. Continu-ous variables were expressed as meanϮstandard deviation or median, categorical data were expressed as proportions. Comparisons were performed by using Student t test, Mann-Whitney U test, 2 test, or Fisher exact test as appropriate at a level of significance of PϽ0.05. Propensity analyses were carried out by using logistic regression models with stepwise backward procedure. To build the propensity score, 22 preoperative dichotomous variables indicated in Table 1 were used to compute the propensity score. Propensity score allowed for providing an estimate of probability to get into the BH or CA treatment group. The C-statistics for propensity score models were calculated. For analysis the logits of propensity score were used allowing a covariate adjusted outcome analysis. 26, 27 To assess the impact of treatment strategy on outcome a propensity score adjusted logistic regression analysis was performed. Results are described as odds ratios (ORs) and 95% confidence intervals (CIs).
Overall survival and freedom from MACCE and repeated revascularization during a 5-year follow-up period were calculated by using Kaplan-Meier methods and log-rank-test. Cox regression models were adjusted for propensity score and multiple covariates that potentially affect postoperative outcome. Mid-term analyses were based on all patients including hospital deaths. PϽ0.05 were considered statistically significant. The statistical analyses were performed using 13.0 SPSS software package. The authors had full access to the data and take full responsibility for its integrity. All authors read and agree to the manuscript as written.
Results
CS was present in 24 of 380 patients in the CA (6.3%) and in 83 of 240 patients (34.6%) in the BH group. CS was associated with a significant propensity to receive BH surgery (univariate OR, 8.23; 95% CI, 5.0 to 13.5, PϽ0.001; multivariate OR, 3.8; 95% CI, 1.7 to 8.5, Pϭ0.001). Demographics and preoperative hemodynamic status for BH versus CA in presence or absence of CS are given in Table 1 . Table 2 . In BH patients, time from skin incision to culprit lesion revascularization including IMA harvesting was significantly reduced. A total of 102 of 157 (65.0%) of the BH patients were planned for OPCAB procedure. In 5 patients (4.9%) conversion to OnP-BH was required because of inadequate visualization of the target vessel (nϭ1), deep intramyocardial course of the LAD (1) and hemodynamic compromise (3). In OnP-BH patients, CPB time was significantly prolonged compared with CA patients. In BH patients less distal anastomoses to LAD, right coronary artery, and circumflex artery territory were performed leading to a reduced completeness of revascularization (BH 82.2% versus CA 89.3%).
Propensity score-adjusted perioperative outcome is given in Table 3 . A significantly lower number of BH patients required postoperative inotropic support; however, incidence of postoperative low output syndrome was similar between the groups. Mean blood loss was reduced associated with lower reexploration rate and transfusion requirement in BH patients. Clinical data concerning myocardial injury were comparable as no difference in new MI or atrial fibrillation was evident. However, bypass dysfunction revealed by postoperative reangiography was slightly higher in BH patients. Extracardiac morbidity (total ventilation time, stroke rate, and gastrointestinal complications) was lower leading to a reduced intensive care unit (ICU) and hospital stay in BH patients. Hospital mortality was lower in BH patients (BH 5.7% versus CA 8.6%) without reaching statistical significance. Multivariate analysis including 22 preoperative variables, completeness of revascularization, and all dichotomous outcome variables mentioned in Table 3 
Patients With CS
Patient cohorts were comparable as indicated in Table 1 . No significant selection bias for the one or the other treatment strategy could be identified. The C-statistic for propensity score model was 88.6%. Operative data for the CS subgroup are given in Table 4 . Time interval from skin incision to culprit lesion revascularization was shorter in BH patients. Three of 22 (13.6%) patients planned for OPCAB procedure had to be converted to OnP-BH surgery because of hemodynamic instability during cardiac manipulation. CPB time and rate of revascularization of LAD, circumflex artery, and right coronary artery territories were comparable between the groups. In CA patients more distal anastomoses were performed; however, that did not significantly affect the completeness of revascularization (BH 88.0% versus CA 79.2%). Propensity score-adjusted outcome analysis revealed a benefit of BH surgery concerning incidence of postoperative atrial fibrillation, acute renal failure, stroke rate, and sternal would complications, respectively ( Table 5 ). Hospital mortality was also reduced in BH patients (BH 19.3% versus CA 33.3%; Pϭ0.048). In multivariate analysis no independent predictor for hospital mortality could be identified.
Perioperative CKMB Release
Preoperative and early postoperative CKMB fractions for all ACS types are shown in Figure 1 . In UA baseline levels were comparable. On postoperative day 1, CKMB increase was 4.5-times (CA) versus 2.7-times (BH) the baseline level (PϽ0.001). On postoperative day 2, CKMB level was also higher in CA patients (PϽ0.001), but without significant difference compared with postoperative day 1 levels. In NSTEMI patient baseline levels were significantly higher in BH patients (PϽ0.001). However, CKMB levels were comparable during the early postoperative course related to baseline level. For STEMI patients baseline as well as postoperative day 1 concentrations were comparable between BH and CA patients, with a trend to lower levels on postoperative day 2 for BH patients (Pϭ0.103).
Follow-Up
Median follow-up among 573 hospital survivors was 2.78 years (range, 0.02 to 5.86 years). There were 62 deaths after hospital discharge. No patients received surgical coronary reintervention, 23 For patients with stable hemodynamics, median follow-up was 3.3 years (95% CI, 3.1 to 3.5 years). Kaplan-Meier overall 4-year survival rate including hospital deaths was 84.1% (95% CI, 77.5 to 90.8%) for BH patients versus 82.1% (95% CI, 77.8% to 86.2%) for patients operated on the arrested heart. The MACCE-free 4-year survival rate was 78.2% for BH patients (95% CI, 69.4 to 87.0%) compared with 74.5% (95% CI, 69.6 to 79.5%) for cardioplegic arrested heart patients. As indicated in Figure 2a and 2b there were no significant differences between BH and CA patients.
For patients presenting cardiogenic shock at the time of operation, median follow-up was 2.5 years (95% CI, 2.3 to 2.7 years). Overall 4-year survival rate including hospital deaths was 60.3% (95% CI, 44.6% to 76.1%) for BH patients versus 44.5% (95% CI, 29.6% to 69.5%) for patients operated on the arrested heart. The MACCE-free 4-year survival rate was 56.4% for BH patients (95% CI, 41.5% to 71.7%) compared with 36.1% (95% CI, 14.9% to 57.2%) for cardioplegic arrested heart patients. As shown in Figure 2c and 2d, there were also no significant differences between BH and CA patients.
Discussion
Current indications for emergency CABG surgery in ACS patients are limited to those presenting with evolving myocardial ischemia refractory to optimal medical therapy, presence of left main stenosis and/or 3-vessel disease, ongoing ischemia despite successful or failed PCI, complicated PCI, or cardiogenic shock accompanied by complex coronary anatomy. Patients that meet these indications are relatively rare, representing only 3.3% of all stand-alone CABG procedures during the study period at our institution. It can be speculated that maintaining native coronary blood and avoiding global myocardial ischemia is the optimal treatment strategy for ACS patients whenever CABG surgery is indicated. Based on the experience in high-risk patients, 10 -13,21-24 we therefore extended our indication for BH surgery to emergency ACS patients as an alternative to conventional CABG. One interesting finding from our 5-year experience is that there was a significant bias to perform BH surgery in sicker patients and in presence of CS. This is in accordance with other studies that demonstrated a selection bias of sicker patients for on-pump BH techniques. 21 However, BH patients demonstrated less left main and circumflex artery disease. To perform appropriate statistical analysis, we therefore computed a propensity score for the individual patient according to the hemodynamic status at the beginning of the operation that allows a risk-adjusted evaluation.
In comparison to other studies focusing on AMI, we included all patients with ACS according to the current nomenclature.
Patients with Stable Hemodynamics
Perioperative mortality for emergency revascularization in AMI patients presenting under stable hemodynamic condition and using conventional CABG is varying. Creswell et al indicated a mortality rate of patients operated within 6 hours after onset of AMI symptoms of 9.1%. 17 In a multicenter analysis of 32 099 patients who underwent conventional CABG within 24 hours after AMI, hospital mortality was 14%. 19 Tomasco et al indicated a similar mortality rate of 13.4% for patients operated within 24 hours after AMI. 15 However, Sergeant et al found a remarkably lower mortality rate of 1.6% for this subset of patients. 16 Prospective or risk-adjusted analyses comparing BH and CA strategies for this subgroup are not available so far. In a retrospective analysis of 225 patients operated within Ͻ7 days after AMI, Locker reported a significantly reduced perioperative mortality for the OPCAB group. 22 The present analysis on a large number of patients revealed a trend toward a lower mortality in stable patients when operated by BH strategies. However, perioperative morbidity was significantly reduced as indicated by lower requirement for postoperative inotropic support, less blood loss, shorter ventilation time, less gastrointestinal complications, and lower stroke rate. This is in concordance to other studies that demonstrated lower neurological injury in off-pump surgery in elective patients. 28 -30 38% of our patients were operated with CPB support that did not significantly affect the postoperative neurological status. It remains speculative that preserved pulsatile blood flow plays a key role in preventing neurological injury.
BH patients received less grafts to all 3 coronary territories that in parts reflect the lower number of diseased vessels. The completeness of revascularization in BH patients was 82.2% and significantly lower than in CA patients, but did not affect the LAD territory. Postoperative inotropic support was reduced in BH patients. Nevertheless, we found a trend for more frequent IABP implantation in BH patients. This most likely reflects a bias for rather prophylactical IABP implantation in BH surgery to obtain better perioperative hemodynamics support.
Patients With Cardiogenic Shock
Patients with CS have a mortality rate ranging from 21.3% to 46.7%. 15, 16, 31 The data from the SHOCK trial particularly revealed a benefit of early revascularization strategies and also superiority of CABG compared with PCI. However, hospital mortality of CABG procedures in that trial was 39.6%. 31 Finding comparable preoperative risk factors in our study, hospital mortality was significantly reduced by using BH strategies including OnP-BH in 77.1%. By definition it is uncertain to idenitfy lingering perioperative MI in most of these patients, but we found less inotropic support, a lower rate of new MI, and a significantly lower rate of postoperative atrial fibrillation that might indicate less perioperative myocardial injury. The incidence of atrial fibrillation was high as occurred in 62.5% of CA patients compared with 39.8% in BH patients. Because we could no find a significant difference in atrial fibrillation between BH and CA strategies for stable patients, it can be speculated that the severity of preoperative myocardial damage triggers the devel-opment of atrial fibrillation and BH surgery might have an influence on that. 32 Stroke rate and the incidence of acute renal failure were also significantly reduced in BH patients, although most of the BH operations were performed with CPB support. It might be speculated that a faster postoperative cardiac recovery and preserved pulsatility have a protective potential. Thus, BH strategy is advantageous to reduce extracardiac complications in these high-risk patients, although a renoprotective effect of BH surgery in elective patients is controversially discussed. [33] [34] [35] 
CKMB Enzyme Release
There is consistent evidence of reduced CKMB enzyme release in elective OPCAB surgery. 2, 4, 5, 10 However, none of these studies could demonstrate clinical significance of these findings as the differences were rather small. We analyzed the CKMB levels separately for the different ACS types. For UA we could demonstrate a lower release of CKMB on postoperative day 1 in BH compared with CA patients. That is consistent to findings in elective patients. 2, 4, 5 In STEMI and in NSTEMI patients we did not find a significant difference in CKMB levels between cardioplegic and BH surgery on postoperative day 1 and postoperative day 2. It can be concluded that the extent of myocardial necrosis induced by cardioplegic CA is low compared with that caused by the AMI itself. For these patients other mechanisms like faster revascularization of the culprit lesion, attenuated "no reflow phenomenon," or reduced myocardial edema might lead to a better outcome when using BH strategies.
Follow-Up
BH and CA surgery late survival was comparable with significant worse survival in cardiogenic shock patients. Locker et al found a worse 5-year survival rate for OPCAB patients compared with CA patients. 22 One reason for these inconsistent findings might be the patient selection, because Locker included patients with AMI within 1 week and only few CS patients. Moreover, he considered OPCAB patients only, whereas our patients were operated both OPCAB and OnP-BH. However, we also found a reduced completeness of revascularization in the noncardiogenic shock patients when using BH surgery. Surprisingly, incompleteness of revascularization in our multivariate analysis was not a risk factor for late death, MACCE, or repeated revascularization. One reason might be that completeness of the LAD territory revascularization was similar between CA and BH patients. Diabetes could be identified as a major risk factor for late mortality and cardiac morbidity.
Limitations
There are some limitations of the present study. First of all it is nonrandomized. However, using specific statistical evaluations it allows for relatively precise risk and outcome assessment and comparison. The propensity score shares the limitations of all risk models and can only account for factors that are known.
Beside propensity score adjusted multivariate analysis used in this study propensity score can also serve for matching and stratification. Using propensity score-adjusted matching in acceptable variance, we could only include 26% of all patients for comparison excluding most of the high-risk patients. Using risk stratification by producing quintiles the patient numbers in 2 of the quintiles were too small to allow for comprehensive analysis. Therefore, in the current data analysis the propensity score was used as a covariate in traditional regression model producing more convincing results by considering the entire study population. 27 The purpose of our study was to analyze the impact of preserved native coronary blood flow during emergency Figure 2 . Propensity score adjusted long-term survival including hospital deaths in patients with stable hemodynamics (a) and in cardiogenic shock (c) according to the operative strategy. Additionally adjusted follow-up MACCE rate for hemodynamically stable (b) and cardiogenic shock (d) patients were given. treatment for ACS. However, in the BH cohort patients were operated with or without extracorporeal circulation according to the surgeon's assessment and the clinical status of the patient. Within the arrested heart cohort the use of antegrade/ retrograde blood and cristalloid cardioplegia was not standardized and decision was made on an individual basis. We could not totally exclude selection bias for blood versus cristalloid cardioplegic arrest that was not adjusted by propensity score analysis.
